In Phase II Clinical Trials
Development of Effective and Innovative Medicines to Address the needs of Patients and Improve their Health, Longevity and Quality of Life.
Hub Controls
  • Demo Video
  • Upload Photo
  • Edit Company Profile
  • Add a Link
  • Update Fast Facts
  • Add Management Bios
  • Private Messages
  • Edit My Profile
  • View/Edit My Portfolio

Email Updates

Search
AGORACOM News Flash

MARKET PRESSURE = BUYING OPPORTUNITIES

As predicted on the AGORACOM Blog, it appears we are now moving into capitulation phase and a great opportunity to buy good small-caps that have been thrown out with the bathwater. 

Follow AGORACOM commentary on:

  George's Blog    Grandich Blog

AGORACOM Micro-Blog

Close
AlphaRx > Message
Generic_profile

Re: NEWS - AlphaRx's Nanoparticle Formulation of Antituberculosis Drug Shows Promise in Mice Infected With TB (Mycobacterium Tuberculosis)

Posted by: supernova on February 20, 2007 11:33AM

In response to: NEWS - AlphaRx's Nanopartic... by AGORACOM

Great news, great science, sky is the limit.
Did You Know?

You can ignore an AGORACOM member by clicking on "ignore user" at the top of any of their posts

Log in to Recommend Up_g

0 members recommend this.

Post a Reply

Please login to reply to this message.

Subscribe to Rss Feed
Executive Address
Alrxsmall
Michael Lee
President
May 18, 2006

 

Michael Lee provides the investor community an update on recent events

View Broadcast

Stock Quote
Open alrx Stock Quote